Skip to main content

GKSL · Gujarat Kidney And Super Speciality Limited

155.69 INR -1.18 (-0.75%) At close · Nov 13
Market Cap
12.28B INR
Shares
78.84M
Volume · Nov 13 159.93K Avg daily vol (3M) 1.34M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Investor day
Close155.69 INR Open156.87 INR Day154.90–156.97 INR Available close range99.36–194.69 INR Avg vol 30d1.9M Last earningsNov 5, 2026 DataDec 2025–Nov 2026

The closing range uses available history since Dec 30, 2025; less than a full year is stored.

Latest documents

2026
Nov 5
Earnings call
Revenue doubles as expansion broadens into Dubai

Gujarat Kidney And Super Speciality reported H1 F527 consolidated revenue from operations of 72.4 crore, up 157% year-on-year. It acquired a 51% stake in a Dubai polyclinic with an existing revenue base of approximately 20 crore.

2 source passages
In H1 F527, consolidated revenues from operations 2 at 72.4 crore up to 157% stage year-on-year from 28.2 crore in H1 F26. Another important opportunity is Dubai where we have acquired a 51% stake in established polyclinic with an existing revenue base of approximately 20 crore. Open the document at this passage
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its available closing range
Range low 99.36 INR Now 155.69 INR · 59% Range high 194.69 INR
vs 200-day avg +14% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:GKSL -0.2% -17.9% +8.7% -4.7% +51.2%

Exchange listing

Market
XNSE
Ticker
GKSL
ISIN
INE0V0W01025
Security
Ordinary share
Trading currency
INR

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026